<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03869528</url>
  </required_header>
  <id_info>
    <org_study_id>510 RCT</org_study_id>
    <nct_id>NCT03869528</nct_id>
  </id_info>
  <brief_title>5 Versus 10 Sprays of Lignocaine for Pharyngeal Anaesthesia During Bronchoscopy</brief_title>
  <official_title>A Randomized Controlled Trial to Evaluate the Efficacy of Topical Pharyngeal Anaesthesia Using 5 vs 10 Sprays of 10% Lignocaine During Flexible Bronchoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>All India Institute of Medical Sciences, New Delhi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All India Institute of Medical Sciences, New Delhi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Flexible bronchoscopy is one of the most widely performed procedures for diagnosis of various&#xD;
      bronchopulmonary diseases. Most patients tolerate the procedure well although cough is often&#xD;
      reported as a distressing symptom. It is likely that the acceptance of bronchoscopy would be&#xD;
      significantly improved with control of cough.&#xD;
&#xD;
      Topical lignocaine is administered during bronchoscopy for local anaesthesia. There is&#xD;
      uncertainty regarding the adequate dose of lignocaine sprays for pharyngeal anaesthesia&#xD;
      during flexible bronchoscopy. This study would help to determine the optimal dose of&#xD;
      lignocaine sprays for pharyngeal anaesthesia during flexible bronchoscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For all patients meeting the inclusion criteria, the demographic profile including age, sex,&#xD;
      weight and the type of procedures performed during bronchoscopy shall be recorded. A written&#xD;
      informed consent will be obtained from all participants. Enrolled patients will be randomized&#xD;
      to receive either 5 or 10 sprays of 10% lignocaine to the pharynx. This will be followed by&#xD;
      the standard topical anesthesia procedure followed in our institution involving 5ml of 2%&#xD;
      lignocaine gel into the nostril. Transnasal flexible bronchoscopy will be performed with&#xD;
      additional 1% lignocaine administered as &quot;spray as you go&quot; method. This will be given as 2 ml&#xD;
      aliquots- with similar volume in both groups as baseline. Procedure shall be performed with&#xD;
      administration of sedation using Midazolam and Fentanyl if required. Primary outcome will be&#xD;
      assessed by noting the operator rated overall procedure satisfaction as a VAS scale score.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Controlled Trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Group allocation by opaque sealed envelopes. Participant and bronchoscopist shall be unaware of the number of sprays administered.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Operator rated overall procedure satisfaction</measure>
    <time_frame>At study completion at approximately 4 months</time_frame>
    <description>Visual Analogue Scale score (VAS) between 0 to 100</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operator rated cough</measure>
    <time_frame>At study completion at approximately 4 months</time_frame>
    <description>Visual Analogue score (VAS) between 0 to 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from bronchoscope introduction to reaching the vocal cords</measure>
    <time_frame>At study completion at approximately 4 months</time_frame>
    <description>Time in seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient willingness to return for repeat bronchoscopy</measure>
    <time_frame>At study completion at approximately 4 months</time_frame>
    <description>Proportion of patients willing for repeat bronchoscopy in each group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative lignocaine dose</measure>
    <time_frame>At study completion at approximately 4 months</time_frame>
    <description>Total dose of lignocaine in milligram (mg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>At study completion at approximately 4 months</time_frame>
    <description>Proportion of patients with complications in each group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Bronchoscopy</condition>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>5 sprays</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 sprays of 10% lignocaine administered for topical anaesthesia during flexible bronchoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 sprays</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 sprays of 10% lignocaine administered for topical anaesthesia during flexible bronchoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5 sprays of 10% lignocaine</intervention_name>
    <description>5 sprays of 10% lignocaine</description>
    <arm_group_label>5 sprays</arm_group_label>
    <other_name>5 sprays</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>10 sprays of 10% lignocaine</intervention_name>
    <description>10 sprays of 10% lignocaine</description>
    <arm_group_label>10 sprays</arm_group_label>
    <other_name>10 sprays</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All adults ≥ 18 yrs of age undergoing flexible bronchoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Uncontrolled hypertension Systolic Blood Pressure &gt;180 mm Hg&#xD;
&#xD;
          -  Symptomatic coronary artery disease&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Not giving informed consent for the procedure&#xD;
&#xD;
          -  Hypoxemia (oxygen saturation [by pulse oximetry] &lt; 92% with Fio2 of ≥ 0.3&#xD;
&#xD;
          -  Bronchoscopy performed through an artificial airway&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randeep Guleria, MD DM</last_name>
    <role>Study Chair</role>
    <affiliation>AIIMS, New Delhi</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karan Madan, MD DM</last_name>
    <phone>00911126593488</phone>
    <email>drkaranmadan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anant Mohan, MD</last_name>
    <phone>00911126593006</phone>
    <email>anantmohan@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AIIMS</name>
      <address>
        <city>New Delhi</city>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karan Madan, MD, DM</last_name>
      <email>drkaranmadan@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Anant Mohan, MD</last_name>
      <email>anantmohan@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Karan Madan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AIIMS Rishikesh</name>
      <address>
        <city>Rishīkesh</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mayank Mishra</last_name>
      <email>virgodrmayank@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Girish Sindhwani</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>March 8, 2019</study_first_submitted>
  <study_first_submitted_qc>March 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2019</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>All India Institute of Medical Sciences, New Delhi</investigator_affiliation>
    <investigator_full_name>Karan Madan</investigator_full_name>
    <investigator_title>Dr Karan Madan, Assistant Professor, Department of Pulmonary Medicine and Sleep Disorders</investigator_title>
  </responsible_party>
  <keyword>bronchoscopy</keyword>
  <keyword>lignocaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

